25 May 2013
Keywords: starlix, cleared, eu, novartis, been, awarded, marketing
Article | 05 April 2001
Novartis has been awarded marketing approval in the European Union forStarlix (nateglinide), its drug for the treatment of type 2 diabetes.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 April 2001
24 May 2013
© 2013 thepharmaletter.com